Home - Products - Others - Other Targets - Disomotide TFA 181477-43-0(free base)

Disomotide TFA 181477-43-0(free base)

CAS No. ——

Disomotide TFA 181477-43-0(free base)( —— )

Catalog No. M22902 CAS No. ——

Disomotide is an oligopeptide for the treatment of melanoma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Disomotide TFA 181477-43-0(free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    Disomotide is an oligopeptide for the treatment of melanoma.
  • Description
    Disomotide is an oligopeptide for the treatment of melanoma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    1149.24
  • Molecular Formula
    C49H75F3N10O16S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C(F)(F)F.CC(C)[C@@H](C(O)=O)NC([C@H](CO)NC([C@H](CC1=CC=CC=C1)NC([C@H]2N(C([C@H](C(C)C)NC([C@H](CCC(N)=O)NC([C@H](CC(O)=O)NC([C@H](CCSC)NC([C@H]([C@@H](C)CC)N)=O)=O)=O)=O)=O)CCC2)=O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bayes M , Rabasseda X , Prous J R . Gateways to Clinical Trials[J]. methods & findings in experimental & clinical pharmacology, 2008, 30(4):313.
molnova catalog
related products
  • 5-hydroxy-3,7-dimeth...

    5-hydroxy-3,7-dimethoxy-2-phenylchromen-,a natural product obtained from the resinous exudate of Heliotropium huascoense.

  • Tetracosactide aceta...

    Cosyntropin (acetate) stimulates the release of corticosteroids such as cortisol from the adrenal gland.

  • Rac1 Inhibitor F56, ...

    Control peptide version of Rac1 Inhibitor; comprises residues 45-60 of Rac1 with Trp56 replaced by Phe. Does not affect GEF-Rac1 interaction.